OCULAR THERAPEUTIX INC (OCUL:NASDAQ)
$9.7 -0.18 (-1.8219%)
Analysed OCULAR THERAPEUTIX INC (OCUL:NASDAQ) News Sources
Ocular Therapeutix vs. Prime Medicine: Which Healthcare Stock Is a Better Buy in 2026?
15-06-2026
fool.com
Ocular Therapeutix™ Investor Day to Highlight U.S. FDA Alignment on AXPAXLI™ NDA with Submission Planned for Fourth Quarter 2026
17-06-2026
yahoo.com
OCUL Stock Is Climbing Ahead Of Investor Day — What Is On The Agenda?
17-06-2026
stocktwits.com
Why Ocular Therapeutix (OCUL) Stock Is Up Today
17-06-2026
yahoo.com
Stocks making big moves yesterday: Nubank, Ocular Therapeutix, Mondelez, ResMed, and Sonos
18-06-2026
yahoo.com
Ocular Therapeutix (OCUL): Buy, Sell, or Hold Post Q1 Earnings?
24-06-2026
yahoo.com
Is Ocular Therapeuticx, Inc. (OCUL) Stock Positioned for Growth After Positive FDA Feedback on Axpaxli?
25-06-2026
yahoo.com
Ocular Therapeutix™ to Participate in July Scientific and Investor Conferences
01-07-2026
yahoo.com
3 Small-Cap Stocks with Open Questions
08-07-2026
yahoo.com
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09-07-2026
yahoo.com
What is the current price of OCULAR THERAPEUTIX INC (OCUL:NASDAQ)?
The current price of OCULAR THERAPEUTIX INC (OCUL:NASDAQ) is $9.7.
OCULAR THERAPEUTIX INC (OCUL:NASDAQ) absolute price change since previous trading day?
The absolute price change of OCULAR THERAPEUTIX INC (OCUL:NASDAQ) since the previous trading day is $-0.18.
OCULAR THERAPEUTIX INC (OCUL:NASDAQ) percentage price change since previous trading day?
The percentage price change of OCULAR THERAPEUTIX INC (OCUL:NASDAQ) since the previous trading day is -1.8219%.
What is the most recent average sentiment score for OCULAR THERAPEUTIX INC (OCUL:NASDAQ)?
The most recent average sentiment score for OCULAR THERAPEUTIX INC (OCUL:NASDAQ) is 54 out of 100.
What is the most recent average sentiment for OCULAR THERAPEUTIX INC (OCUL:NASDAQ)?
The most recent sentiment for OCULAR THERAPEUTIX INC (OCUL:NASDAQ) is .
SEC-8K** Filing Available For OCULAR THERAPEUTIX INC (OCUL:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.